LNTH FY 2023 Earnings — Lantheus Holdings, Inc. Revenue & Financial Results | Market Cap Arena

LNTHLantheus Holdings, Inc.

$6B

FY 2023 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$1.3B+38.6% YoY

Gross Profit

$710M54.7% margin

Operating Income

$365M28.1% margin

Net Income

$327M25.2% margin

EPS (Diluted)

$4.65

Cash Flow

Operating Cash Flow

$305M

Free Cash Flow

$259M

Stock-Based Comp.

$51M

Balance Sheet

Total Assets

$1.7B

Total Liabilities

$835M

Stockholders' Equity

$816M

Cash & Equivalents

$714M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.3B	$935M	+38.6%
Gross Profit	$710M	$582M	+22.0%
Operating Income	$365M	$36M	+907.4%
Net Income	$327M	$28M	+1063.9%